Attribution of causality in Stevens-Johnson syndrome/toxic epidermal necrolysis. [PDF]
Parvathaneni A +7 more
europepmc +1 more source
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use. [PDF]
Heerfordt IM +4 more
europepmc +1 more source
Paediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: patterns and outcomes in a retrospective Pakistani cohort. [PDF]
Rahman A +6 more
europepmc +1 more source
Correction: Immune checkpoint inhibitor-related Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective analysis of 21 cases. [PDF]
Pu T, Teng Y, Zhang Y, Da M, Wang F.
europepmc +1 more source
Effective management of pembrolizumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with upadacitinib. [PDF]
Goetz L, Wang B.
europepmc +1 more source
Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: A review of current management and changing trends. [PDF]
Akgun Z, Can GD, Selver OB.
europepmc +1 more source
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review of Ophthalmic Management and Treatment. [PDF]
Sawires K +6 more
europepmc +1 more source
Fatal Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Advanced Lung Adenocarcinoma. [PDF]
Chang PC, Chang TW, Kuo CY, Wu YZ.
europepmc +1 more source
Stevens-Johnson syndrome/toxic epidermal necrolysis induced by tislelizumab: a case report and literature review. [PDF]
Yu H, Li Y, Qu X, Zhu J, Liu Z, Mu Z.
europepmc +1 more source
Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: age-stratified insights from the FAERS database. [PDF]
Bayram-Ozgur D +5 more
europepmc +1 more source

